# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-14-001020
Filing Date
2014-04-02
Accepted
2014-04-02 17:28:14
Documents
5
Period of Report
2014-05-22
Effectiveness Date
2014-04-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | t1400573_def14a.htm | DEF 14A | 347373
2 | GRAPHIC | pc_1.jpg | GRAPHIC | 961102
3 | GRAPHIC | pc_2.jpg | GRAPHIC | 817482
4 | GRAPHIC | pc_3.jpg | GRAPHIC | 851321
5 | GRAPHIC | pc_4.jpg | GRAPHIC | 703587
| Complete submission text file | 0001571049-14-001020.txt |  | 4941880

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 14739404
SIC: 2834 Pharmaceutical Preparations